Moderna insider trading
MRNAfinancial statementsForm 4 filings on EDGAR256 transactions since Nov 1, 2024
From August 4, 2026 to November 1, 2026, 0 insiders at Moderna bought $0 of stock in the open market, and 4 sold $63M. Officers and directors accounted for $0 of purchases and $63M of sales. The last reported transaction was an option exercise by Hoge Stephen on October 15, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through October 16, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $63MAug 4, 2026 – Nov 1, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Oct 30, 2026. Insider data through Nov 1, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
256 transactions from November 1, 2024 to November 1, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2026 | Hoge Stephen | President | option exercise | 76,452 | $12.21 | $933K | 2M | Oct 16, 2026 |
| Oct 15, 2026 | Hoge Stephen | President | open-market sale10b5-1 | 39,145 | $220.72 | $9M | 2M | Oct 16, 2026 |
| Oct 14, 2026 | Hoge Stephen | President | option exercise | 76,453 | $12.21 | $933K | 2M | Oct 16, 2026 |
| Oct 14, 2026 | Hoge Stephen | President | open-market sale10b5-1 | 38,774 | $213.47 | $8M | 2M | Oct 16, 2026 |
| Oct 14, 2026 | Hoge Stephen | President | open-market sale10b5-1 | 450 | $214.15 | $96K | 2M | Oct 16, 2026 |
| Oct 5, 2026 | Mock James M | Chief Financial Officer | option exercise | 1,454 | — | — | 60,829 | Oct 7, 2026 |
| Oct 5, 2026 | Mock James M | Chief Financial Officer | tax withholding | 704 | $190.01 | $134K | 60,125 | Oct 7, 2026 |
| Sep 15, 2026 | Hoge Stephen | President | option exercise | 76,452 | $12.21 | $933K | 2M | Sep 16, 2026 |
| Sep 15, 2026 | Hoge Stephen | President | open-market sale10b5-1 | 40,281 | $146.07 | $6M | 2M | Sep 16, 2026 |
| Sep 14, 2026 | Hoge Stephen | President | option exercise | 76,453 | $12.21 | $933K | 2M | Sep 16, 2026 |
| Sep 14, 2026 | Hoge Stephen | President | open-market sale10b5-1 | 40,294 | $144.13 | $6M | 2M | Sep 16, 2026 |
| Sep 10, 2026 | Mock James M | Chief Financial Officer | option exercise | 19,836 | $30.96 | $614K | 94,211 | Sep 14, 2026 |
| Sep 10, 2026 | Mock James M | Chief Financial Officer | open-market sale10b5-1 | 19,836 | $134.49 | $3M | 74,375 | Sep 14, 2026 |
| Sep 10, 2026 | Mock James M | Chief Financial Officer | open-market sale10b5-1 | 15,000 | $134.49 | $2M | 59,375 | Sep 14, 2026 |
| Sep 4, 2026 | Mock James M | Chief Financial Officer | option exercise | 11,797 | — | — | 80,079 | Sep 8, 2026 |
| Sep 4, 2026 | Mock James M | Chief Financial Officer | tax withholding | 5,704 | $148.87 | $849K | 74,375 | Sep 8, 2026 |
| Sep 4, 2026 | Klinger Shannon Thyme | Chief Legal Officer | option exercise | 11,797 | — | — | 87,044 | Sep 8, 2026 |
| Sep 4, 2026 | Klinger Shannon Thyme | Chief Legal Officer | tax withholding | 5,704 | $148.87 | $849K | 81,340 | Sep 8, 2026 |
| Sep 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | option exercise | 3,471 | $30.96 | $107K | 77,600 | Sep 3, 2026 |
| Sep 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | open-market sale10b5-1 | 3,471 | $139.95 | $486K | 74,129 | Sep 3, 2026 |
| Sep 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | option exercise | 2,166 | — | — | 76,295 | Sep 3, 2026 |
| Sep 1, 2026 | Klinger Shannon Thyme | Chief Legal Officer | tax withholding | 1,048 | $140.34 | $147K | 75,247 | Sep 3, 2026 |
| Sep 1, 2026 | Mock James M | Chief Financial Officer | option exercise | 2,475 | — | — | 69,479 | Sep 3, 2026 |
| Sep 1, 2026 | Mock James M | Chief Financial Officer | tax withholding | 1,197 | $140.34 | $168K | 68,282 | Sep 3, 2026 |
| Sep 1, 2026 | Hoge Stephen | President | option exercise | 9,283 | — | — | 1M | Sep 3, 2026 |
| Sep 1, 2026 | Hoge Stephen | President | tax withholding | 4,489 | $140.34 | $630K | 1M | Sep 3, 2026 |
| Aug 28, 2026 | Hoge Stephen | President | option exercise | 611 | — | — | 1M | Aug 31, 2026 |
| Aug 28, 2026 | Hoge Stephen | President | tax withholding | 296 | $142.77 | $42K | 1M | Aug 31, 2026 |
| Aug 28, 2026 | Klinger Shannon Thyme | Chief Legal Officer | option exercise | 329 | — | — | 74,289 | Aug 31, 2026 |
| Aug 28, 2026 | Klinger Shannon Thyme | Chief Legal Officer | tax withholding | 160 | $142.77 | $23K | 74,129 | Aug 31, 2026 |
| Aug 28, 2026 | Mock James M | Chief Financial Officer | option exercise | 329 | — | — | 67,164 | Aug 31, 2026 |
| Aug 28, 2026 | Mock James M | Chief Financial Officer | tax withholding | 160 | $142.77 | $23K | 67,004 | Aug 31, 2026 |
| Aug 27, 2026 | Hoge Stephen | President | option exercise | 1,437 | — | — | 1M | Aug 31, 2026 |
| Aug 27, 2026 | Hoge Stephen | President | tax withholding | 695 | $149.66 | $104K | 1M | Aug 31, 2026 |
| Aug 27, 2026 | Klinger Shannon Thyme | Chief Legal Officer | option exercise | 774 | — | — | 74,335 | Aug 31, 2026 |
| Aug 27, 2026 | Klinger Shannon Thyme | Chief Legal Officer | tax withholding | 375 | $149.66 | $56K | 73,960 | Aug 31, 2026 |
| Aug 27, 2026 | Mock James M | Chief Financial Officer | option exercise | 774 | — | — | 67,210 | Aug 31, 2026 |
| Aug 27, 2026 | Mock James M | Chief Financial Officer | tax withholding | 375 | $149.66 | $56K | 66,835 | Aug 31, 2026 |
| Aug 6, 2026 | Bancel Stephane | Chief Executive Officer, Director | option exercise | 252,469 | $19.15 | $5M | 6M | Aug 7, 2026 |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer, Director | option exercise | 499,246 | $19.15 | $10M | 7M | Aug 7, 2026 |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer, Director | open-market sale10b5-1 | 147,473 | $56.21 | $8M | 7M | Aug 7, 2026 |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer, Director | open-market sale10b5-1 | 124,838 | $56.96 | $7M | 6M | Aug 7, 2026 |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer, Director | open-market sale10b5-1 | 39,891 | $58.12 | $2M | 6M | Aug 7, 2026 |
| Aug 5, 2026 | Bancel Stephane | Chief Executive Officer, Director | open-market sale10b5-1 | 187,044 | $58.79 | $11M | 6M | Aug 7, 2026 |
| Jul 15, 2026 | Hoge Stephen | President | option exercise | 37,226 | $19.15 | $713K | 2M | Jul 16, 2026 |
| Jul 15, 2026 | Hoge Stephen | President | option exercise | 16,110 | $19.15 | $309K | 2M | Jul 16, 2026 |
| Jul 15, 2026 | Hoge Stephen | President | open-market sale10b5-1 | 53,336 | $67.60 | $4M | 1M | Jul 16, 2026 |
| Jul 2, 2026 | Mock James M | Chief Financial Officer | option exercise | 1,452 | — | — | 67,139 | Jul 6, 2026 |
| Jul 2, 2026 | Mock James M | Chief Financial Officer | tax withholding | 703 | $72.50 | $51K | 66,436 | Jul 6, 2026 |
| Jun 15, 2026 | Hoge Stephen | President | option exercise | 37,226 | $19.15 | $713K | 2M | Jun 17, 2026 |
Who the insiders are
Everyone who reported a transaction since November 1, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Hoge Stephen | President | Oct 15, 2026 | option exercise | 2M | — | $45M (9) | 9 of 9 |
| Bancel Stephane | Chief Executive Officer, Director | Aug 6, 2026 | option exercise | 6M | — | $29M (4) | 4 of 4 |
| Mock James M | Chief Financial Officer | Oct 5, 2026 | option exercise | 60,829 | — | $5M (2) | 2 of 2 |
| Klinger Shannon Thyme | Chief Legal Officer | Sep 4, 2026 | option exercise | 87,044 | — | $1M (3) | 3 of 3 |
| Afeyan Noubar | Director | May 21, 2026 | option exercise | — | — | $1M (2) | 0 of 2 |
| Hussain Abbas | Director | May 1, 2026 | open-market sale | 12,066 | — | $279K (2) | 2 of 2 |
| Rubenstein David M. | Director | Apr 30, 2026 | option exercise | 9,643 | — | — | — |
| Horning Sandra | Director | Apr 30, 2026 | option exercise | 18,585 | — | — | — |
| Nabel Elizabeth G | Director | Apr 30, 2026 | option exercise | 19,317 | — | — | — |
| Nader Francois | Director | Apr 30, 2026 | option exercise | 32,781 | — | — | — |
| Tallett Elizabeth E | Director | Apr 30, 2026 | option exercise | 4,761 | — | — | — |
| Sagan Paul | Director | Mar 3, 2025 | open-market buy | — | — | — | — |
Questions
Are Moderna insiders buying or selling?
Over the twelve months to November 1, 2026, 6 insiders at Moderna sold $82M of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $82M. Only open-market purchases and sales are counted.
Who sold the most Moderna stock in the last year?
Hoge Stephen (President) sold $45M in 9 open-market sales over the twelve months to November 1, 2026.
Do Moderna executives sell under 10b5-1 plans?
20 of the 22 open-market sales in the last twelve months (91%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Moderna
- Moderna financial statements
- 1 tracked fund holding MRNA
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.